PHARMACOECONOMIC EFFICACY OF ATESOLIZUMAB COMPARED WITH OTHER PD-1 INHIBITORS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AFTER CHEMOTHERAPY ArticleZyryanov S.K., Diyakov I.N.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 13. 2020. С. 5-12
LIPID-LOWERING THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE IN PRIMARY CARE PRACTICES: WHAT HAS CHANGED OVER 7 YEARS? ArticleЗырянов С.К., Фитилев С.Б., Возжаев А.В., Шкребнева И.И., Клюев Д.А., Степанян Л.Н., Данилова А.А., Цай А.Т., Ландышев Н.Н., Воронько Я.Г.Cardiovascular Therapy and Prevention. Том 19. 2020. С. 78-86
CLINICAL PRACTICE GUIDELINES IN THE LIGHT OF NOVEL LEGISLATION ArticleКазаков А.С., Зырянов С.К., Ушкалова Е.А.Русский Медицинский Журнал. Том 28. 2020. С. 15-19
THE FIXED COMBINATION OF DICLOFENAC AND ORPHENADRINE IN THE TREATMENT OF ACUTE PAIN SYNDROMES ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Современная ревматология. Том 12. 2020. С. 100-104
MODERN PHARMACOTHERAPY OF UNCOMPLICATED INFECTIONS OF THE LOWER URINARY TRACT: THE POSITION OF ANTIBACTERIAL AND HERBAL PREPARATIONS ArticleЗырянов С.К., Бутранова О.И., Аль-Раджави А.Urologiia (Moscow, Russia : 1999). 2020. С. 76-84
ECONOMIC CHALLENGES OF ONCOLOGICAL DISEASES’ PHARMACOTHERAPY ArticleUshkalova E.A., Zyryanov S.K., Gopienko I.A.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 13. 2020. С. 64-70
PHARMACOKINETICS OF DORNASE ALPHA IN CYSTIC FIBROSIS IN CHILDHOOD AND ADOLESCENCE ArticleКондакова Ю.А., Кондратьева Е.И., Костюк С.В., Ершова Е.С., Воронкова А.Ю., Шерман В.Д., Шадрина В.В., Зырянов С.К.Medical News of North Caucasus. Том 15. 2020. С. 210-215
OPTIMIZATION OF CLINICAL AND PHARMACOLOGICAL APPROACHES TO THE TREATMENT OF PATIENTS WITH BRONCHIAL ASTHMA ArticleKubaeva M.B., Ivanov D.A., Zyryanov S.K.Journal of Advanced Pharmacy Education and Research. Том 10. 2020. С. 111-114
PERSONALIZED CHOICE OF OPIOID THERAPY IN A PATIENT WITH CHRONIC PAIN SYNDROME ON THE BACKGROUND OF PANCREAS CANCER: CLINICAL CASE REPORT ArticleBobrova O., Zyryanov S., Shnayder N., Petrova M.Archiv Euromedica. Том 10. 2020. С. 83-85
DETERMINATION OF THE EFFECTIVENESS OF ANTIBIOTIC THERAPY BY CONDUCTING THERAPEUTIC DRUG MONITORING ArticleKazanova A.M., Chenkurov M.S., Kopaylo A.A., Ivzhits M.A., Zyryanov S.K.Antibiotiki i Khimioterapiya. Том 65. 2020. С. 29-33
ОПЫТ ПРИМЕНЕНИЯ ТЕРАПЕВТИЧЕСКОГО ЛЕКАРСТВЕННОГО МОНИТОРИНГА У ПАЦИЕНТА С ХИРУРГИЧЕСКИМ СЕПСИСОМ ArticleЗырянов С.К., Бондарева И.Б., Ченкуров М.С., Ивжиц М.А.Трудный пациент. Том 18. 2020. С. 35-39
THERAPEUTIC DRUG MONITORING AS A TOOL TO INCREASE THE EFFECTIVENESS AND SAFETY OF ANTIBIOTIC THERAPY DURING PREGNANCY ArticleIvzhits M.A., Chenkurov M.S., Zyryanov S.K., Bondareva I.B., Kazanova A.M.Акушерство и гинекология: новости, мнения, обучение. Том 8. 2020. С. 87-88
SYMPTOMATIC SLOW-ACTING DRUGS IN THE TREATMENT OF OSTEOARTHRITIS: FOCUS ON GLUCOSAMINE PREPARATIONS ArticleУшкалова Е.А., Зырянов С.К., Затолочина К.Э.Pirogov Russian Journal of Surgery. 2020. С. 104-111
PREVALENCE, RISK FACTORS, AND MONITORING OF AIDS AMONG SYRIANS UNDER THE CIVIL WAR ArticleGushchina Y.S., Zyryanov S.K., Butranova O.I., Haitham Y., Elena B., Al Bawareed O.A.Pharmacophore. Том 11. 2020. С. 77-83
DEVELOPMENT AND VALIDATION OF METHOD FOR THE QUANTITATIVE DETERMINATION OF MEROPENEM IN HUMAN BLOOD PLASMA FOR THERAPEUTIC DRUG MONITORING ArticleKazanova A.M., Stepanova E.S., Makarenkova L.M., Chistyakov V.V., Zyryanov S.K., Senchenko S.P.Khimiko-Farmatsevticheskii Zhurnal. Том 54. 2020. С. 56-60